Deep brain and cortical stimulation for epilepsy

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 6, 2014, Pages

  Sprengers, Mathieu ^a   Vonck, Kristl ^a   Carrette, Evelien ^a   Marson, Anthony G ^b   Boon, Paul ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASYMPTOMATIC DISEASE; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; CLINICAL EFFECTIVENESS; DATA BASE; DEPRESSION; DRUG RESISTANT EPILEPSY; ELECTROSTIMULATION; EPILEPSY; HUMAN; MEMORY DISORDER; NERVE STIMULATION; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SELF REPORT; SOFT TISSUE INFECTION; SYSTEMATIC REVIEW; THALAMUS ANTERIOR NUCLEUS; THERAPY EFFECT; TREATMENT OUTCOME; ADVERSE EFFECTS; BRAIN CORTEX; DEVICES; ELECTRODE IMPLANT; META ANALYSIS; OUTCOME ASSESSMENT; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CEREBRAL CORTEX; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; EPILEPSY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84922805835     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008497.pub2     Document Type: Review

References (79)

1. Fisher RS. Personal communication 2012.
2. Fisher RS, Uematsu S, Krauss GL, Cycyk BJ, Lesser RP, Rise M. A controlled pilot study of centromedian thalamic stimulation for epilepsy. Epilepsia 1991;32 Suppl 3:86. [CENTRAL: CN-00745383]
3. Fisher RS, Uematsu S, Krauss GL, Cysyk BJ, McPherson R, Lesser RP, et al.Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures. Epilepsia 1992;33(5):841-51.
4. Fisher RS. Personal communication 2012.
5. Fisher RS, Salanova V, Witt T, Worth R, Henry T, Gross R, et al.Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010;51(5):899-908.
6. Medtronic. Medtronic DBS therapy for epilepsy: sponsor information. http://www.fda.gov. February 2010.
7. Salanova V, Fisher R. Long term efficacy of the SANTE trial (Stimulation of the Anterior Nucleus of Thalamus for Epilepsy) [abstract no: 2.269]. Proceedings of the 64th Annual Meeting of the American Epilepsy Society; 2010 December 3-7; San Antonio (TX) [accessed 14 February 2011]. 2010. [CENTRAL: CN-00775388]
8. Mc Lachlan RS. Personal communication 2012.
9. McLachlan RS, Pigott S, Tellez-Zenteno JF, Wiebe S, Parrent A. Bilateral hippocampal stimulation for intractable temporal lobe epilepsy: impact on seizures and memory. Epilepsia 2010;51(2):304-7.
10. Morrell MJ. Personal communication 2012.
11. Morrell MJ, Group RNSSiES. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011;77(13):1295-304.
12. Parrent A, Wiebe S, Matijevic S, Janzen L, Piggot S, Kubu C, McLachlan R. Randomized controlled studies of long-term hippocampal stimulation in single patients with temporal lobe epilepsy. Epilepsia 2003;44 Suppl 9:326-7. [CENTRAL: CN-00745104]
13. Tellez-Zenteno JF, McLachlan RS, Parrent A, Kubu CS, Wiebe S. Hippocampal electrical stimulation in mesial temporal lobe epilepsy. Neurology 2006;66(10):1490-4.
14. Van Buren JM, Wood JH, Oakley J, Hambrecht F. Preliminary evaluation of cerebellar stimulation by double-blind stimulation and biological criteria in the treatment of epilepsy. Journal of Neurosurgery 1978;48(3):407-16.
15. Velasco F. Personnal communication 2012.
16. Velasco F, Velasco M, Jimenez F, Velasco AL, Brito F, Rise M, et al.Predictors in the treatment of difficult-to-control seizures by electrical stimulation of the centromedian thalamic nucleus. Neurosurgery 2000;47(2):295-304; discussion -5.
17. Kellinghaus C, Loddenkemper T. Double-blind, randomized controlled study of bilateral cerebellar stimulation. Epilepsia 2006;47(7):1247; author reply 8-9.
18. Velasco F. Personal communication 2012.
19. Velasco F, Carrillo-Ruiz JD, Brito F, Velasco M, Velasco AL, Marquez I, et al.Double-blind, randomized controlled pilot study of bilateral cerebellar stimulation for treatment of intractable motor seizures. Epilepsia 2005;46(7):1071-81.
20. Velasco AL. Personal communication 2012.
21. Velasco AL, Velasco F, Velasco M, Jimenez F, Carrillo-Ruiz JD, Castro G. The role of neuromodulation of the hippocampus in the treatment of intractable complex partial seizures of the temporal lobe. Acta Neurochirurgica Supplement 2007;97(Pt 2):329-32.
22. Velasco AL, Velasco F, Velasco M, Trejo D, Castro G, Carrillo-Ruiz JD. Electrical stimulation of the hippocampal epileptic foci for seizure control: a double-blind, long-term follow-up study. Epilepsia 2007;48(10):1895-903.
23. Wright GD, McLellan DL, Brice JG. A double-blind trial of chronic cerebellar stimulation in twelve patients with severe epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 1984;47(8):769-74.
24. Anderson WS, Kossoff EH, Bergey GK, Jallo GI. Implantation of a responsive neurostimulator device in patients with refractory epilepsy. Neurosurgical Focus 2008;25(3):E12.
25. Andrade DM, Zumsteg D, Hamani C, Hodaie M, Sarkissian S, Lozano AM, et al.Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy. Neurology 2006;66(10):1571-3.
26. Hodaie M, Wennberg RA, Dostrovsky JO, Lozano AM. Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia 2002;43(6):603-8.
27. Lim SN, Lee ST, Tsai YT, Chen IA, Tu PH, Chen JL, et al.Electrical stimulation of the anterior nucleus of the thalamus for intractable epilepsy: a long-term follow-up study. Epilepsia 2007;48(2):342-7.
28. Lim SN, Lee ST, Tsai YT, Chen IA, Tu PH, Chen JL, et al.Long-term anterior thalamus stimulation for intractable epilepsy. Chang Gung Medical Journal 2008;31(3):287-96.
29. Valentin A, Chelvarajah R, Selway R, Vico L, García De Sola R, Garcia Navarrete E, et al.Centromedian thalamic deep brain stimulation for the treatment of refractory generalised and frontal epilepsy: a blinded controlled study. Epilepsia 2012;53 Suppl. 5:32, Abstract no: p104. [CENTRAL: CN-00833257; DOI: 10.1111/j.1528-1167.2012.03677.x]
30. Raftopoulos C, van Rijckevorsel K, Abu Serieh B, de Tourtchaninoff M, Ivanoiu A, Mary G, Gradin C, Duprez T. Chronic electrical stimulation of the mammillary bodies and the mammillothalamic tracts in chronic refractory epilepsy. Neuromodulation 2004;7(2):148.
31. Raftopoulos C, van Rijckevorsel K, Abu Serieh B, de Tourtchaninoff M, Ivanoiu A, Mary G, et al.Epileptic discharges in a mammillary body of a patient with refractory epilepsy. Neuromodulation 2005;8(4):236-40.
32. van Rijckevorsel K, Abu Serieh B, de Tourtchaninoff M, Ivanoiu A, Mary G, Gradin C, Duprez T, Raftopoulos C. Safety and tolerability of deep brain stimulation of mammillary bodies and mammillothalamic area in patients with chronic refractory epilepsy. Epilepsia 2004;45 Suppl 7:164.
33. van Rijckevorsel K, Abu Serieh B, de Tourtchaninoff M, Raftopoulos C. Deep EEG recordings of the mammillary body in epilepsy patients. Epilepsia 2005;46(5):781-5.
34. Boon P. Prospective Randomized Controlled Study of Neurostimulation in the Medial Temporal Lobe for Patients With Medically Refractory Medial Temporal Lobe Epilepsy; Controlled Randomized Stimulation Versus Resection (CoRaStiR). http://www.clinicaltrials.gov/ct2/show/NCT00431457 February 2007, last update: July 2012.
35. Schulze-Bonhage A. Hippocampus stimulation instead of amygdalohippocampectomy. Prospective, randomized study for treatment of mesiotemporal epilepsy [Hippocampusstimulation statt Amygdalohippokampektomie. Prospektive, randomisierte Behandlungsstudie bei mesiotemporaler Epilepsie]. Zeitschrift fur Epileptologie 2009;22(2):89-92. [CENTRAL: CN-00754119; EMBASE: EMBASE 2009227430]
36. Chabardes S. Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy Associated With Dopaminergic Metabolism Deficit. A Randomized, Double Blind, Controlled Trial. www.clinicaltrials.gov/ct/show/NCT00228371. September 2005, last update March 2010. [: CN-00643474]
37. Wiebe S. Medical versus Electrical Therapy for Temporal Lobe Epilepsy (METTLE). www.clinicaltrials.gov/ct/show/NCT00717431. Vol. July 2008, last update: March 2012. [CENTRAL: CN-00643489]
38. Becker MP, Balagtas CC. Marginal modeling of binary cross-over data. Biometrics 1993;49(4):997-1009. [PUBMED: 8117910]
39. Beyenburg S, Stavem K, Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis. Epilepsia 2010;51(1):7-26.
40. Boon P, Vonck K, De Herdt V, Van Dycke A, Goethals M, Goossens L, et al.Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia 2007;48(8):1551-60.
41. Borghs S, de la Loge C, Cramer JA. Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures. Epilepsy & Behavior 2012;23(3):230-4. [PUBMED: WOS:000301657900009]
42. Boëx C, Seeck M, Vulliemoz S, Rossetti AO, Staedler C, Spinelli L, et al.Chronic deep brain stimulation in mesial temporal lobe epilepsy. Seizure 2011;20(6):485-90. [PUBMED: 21489828]
43. Chabardes S, Kahane P, Minotti L, Koudsie A, Hirsch E, Benabid AL. Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic Disorders 2002;4 Suppl 3:S83-93. [PUBMED: 12495878]
44. Chkhenkeli SA, Sramka M, Lortkipanidze GS, Rakviashvili TN, Bregvadze E, Magalashvili GE, et al.Electrophysiological effects and clinical results of direct brain stimulation for intractable epilepsy. Clinical Neurology and Neurosurgery 2004;106(4):318-29. [PUBMED: 15297008]
45. Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia 1998;39(1):81-8. [PUBMED: WOS:000071467600012]
46. Cramer JA, Hammer AE, Kustra RP. Quality of life improvement with conversion to lamotrigine monotherapy. Epilepsy & Behavior 2004;5(2):224-30. [PUBMED: WOS:000220531700014]
47. Curtin F, Elbourne D, Altman DG. Meta-analysis combining parallel and cross-over clinical trials II: Binary outcomes. Statistics in Medicine 2002;21(15):2145-59. [PUBMED: 12210630]
48. de Tisi J, Bell GS, Peacock JL, McEvoy AW, Harkness WF, Sander JW, Duncan JS. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet 2011;378(9800):1388-95. [PUBMED: 22000136]
49. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
50. Devinsky O, Vickrey BG, Cramer J, Perrine K, Hermann B, Meador K, Hays RD. Development of the Quality-of-Life in Epilepsy Inventory. Epilepsia 1995;36(11):1089-104. [PUBMED: WOS:A1995TC20300005]
51. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9. [PUBMED: 11914310]
52. Elisevich K, Jenrow K, Schuh L, Smith B. Long-term electrical stimulation-induced inhibition of partial epilepsy - Case report. Journal of Neurosurgery 2006;105(6):894-7. [PUBMED: WOS:000242431300015]
53. Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, et al.Practice parameter: temporal lobe and localized neocortical resection for epilepsy. Epilepsia 2003;44(6):741-51.
54. Forsgren L, Beghi E, Oun A, Sillanpaa M. The epidemiology of epilepsy in Europe - a systematic review. European Journal of Neurology 2005;12(4):245-53.
55. Franzini A, Messina G, Marras C, Villani F, Cordella R, Broggi G. Deep brain stimulation of two unconventional targets in refractory non-resectable epilepsy. Stereotactic and Functional Neurosurgery 2008;86(6):373-81. [PUBMED: 19033706]
56. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, et al.Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51(1):48-55. [PUBMED: 9674777]
57. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
58. Commission of Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1989;30:389-99.
59. Jehi L. Mesial temporal lobectomy: post-surgical seizure frequency. Textbook of Epilepsy Surgery. Luders HO, 2008:1223-5.
60. Katariwala NM, Bakay RA, Pennell PB, Olson LD, Henry TR, Epstein CM. Remission of intractable partial epilepsy following implantation of intracranial electrodes. Neurology 2001;57(8):1505-7. [PUBMED: 11673602]
61. Khan S, Wright I, Javed S, Sharples P, Jardine P, Carter M, Gill SS. High frequency stimulation of the mamillothalamic tract for the treatment of resistant seizures associated with hypothalamic hamartoma. Epilepsia 2009;50(6):1608-11. [PUBMED: 19243422]
62. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser AW, Mathern G, et al.Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51(6):1069-77.
63. Kwan P, Brodie MJ. Early identification of refractory epilepsy. New England Journal of Medicine 2000;342(5):314-9.
64. Kwan P, Brodie MJ. Definition of refractory epilepsy: defining the indefinable?. Lancet Neurology 2010;9(1):27-9.
65. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
66. Neligan A, Bell GS, Elsayed M, Sander JW, Shorvon SD. Treatment changes in a cohort of people with apparently drug-resistant epilepsy: an extended follow-up. Journal of Neurology, Neurosurgery, and Psychiatry 2012;83(8):810-3. [PUBMED: 22733083]
67. Privitera MD, Welty TE, Ficker DM, Welge J. Vagus nerve stimulation for partial seizures. Cochrane Database of Systematic Reviews 2002, Issue 1. [DOI: 10.1002/14651858.CD002896]
68. Schulze-Bonhage A, Dennig D, Wagner K, .Cordeiro J, Carius A, Fauser S, Trippel M. Seizure control resulting from intrahippocampal depth electrode insertion. Journal of Neurology, Neurosurgery, and Psychiatry 2010;81(3):352-3. [PUBMED: 20185477]
69. Selwa LM, Schmidt SL, Malow BA, Beydoun A. Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy. Epilepsia 2003;44(12):1568-72. [PUBMED: 14636329]
70. Stedman MR, Curtin F, Elbourne DR, Kesselheim AS, Brookhart MA. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2011;40(6):1732-4. [PUBMED: 20026595]
71. Tellez-Zenteno JF, Ronquillo LH, Wiebe S. Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors. Epilepsy Research 2005;65(1-2):101-15. [PUBMED: 16005188]
72. Tomson T, Nashef L, Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurology 2008;7(11):1021-31. [PUBMED: 18805738]
73. Velasco F, Velasco M, Velasco AL, Jiménez F. Effect of chronic electrical stimulation of the centromedian thalamic nuclei on various intractable seizure patterns: I. Clinical seizures and paroxysmal EEG activity. Epilepsia 1993;34(6):1052-64. [PUBMED: 8243357]
74. Velasco F, Velasco M, Velasco AL, Jimenez F, Marquez I, Rise M. Electrical stimulation of the centromedian thalamic nucleus in control of seizures: long-term studies. Epilepsia 1995;36(1):63-71. [PUBMED: 8001511]
75. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 1995;45(2):224-30. [PUBMED: 7854516]
76. Vonck K, Sprengers M, Carrette E, Dauwe I, Miatton M, Meurs A, et al.A decade of experience with deep brain stimulation for patients with refractory medial temporal lobe epilepsy. International Journal of Neural Systems 2013;23(1):1250034. [PUBMED: 23273130]
77. Wiebe S, Matijevic S, Eliasziwa M, Derry PA. Clinically important change in quality of life in epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 2002;73(2):116-20. [PUBMED: WOS:000177059900007]
78. Wille C, Steinhoff BJ, Altenmuller DM, Staack AM, Bilic S, Nikkhah G, et al.Chronic high-frequency deep-brain stimulation in progressive myoclonic epilepsy in adulthood--report of five cases. Epilepsia 2011;52(3):489-96. [PUBMED: 21219312]
79. Zou GY. One relative risk versus two odds ratios: implications for meta-analyses involving paired and unpaired binary data. Clinical Trials 2007;4(1):25-31. [PUBMED: 17327243]